The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of a phase III randomized controlled trial comparing modified gemcitabine + oxaliplatin (mGEMOX) to gemcitabine+ cisplatin in management of unresectable gall bladder cancer (GBC).
 
Atul Sharma
Research Funding - CD Pharma India; CD Pharma India (Inst)
 
Nootan Kumar Shukla
No Relationships to Disclose
 
Surendra Pal Chaudhary
Research Funding - CD Pharma India; CD Pharma India (Inst); SCRI Singapore Clinical Research Institute; SCRI Singapore Clinical Research Institute (Inst)
 
Ranjit Sahoo
No Relationships to Disclose
 
BK Mohanti
No Relationships to Disclose
 
S. V. S. Deo
No Relationships to Disclose
 
Sujoy Pal
No Relationships to Disclose
 
Sanjay Thulkar
No Relationships to Disclose
 
Sunil Kumar
No Relationships to Disclose
 
Sushmita Pathy
No Relationships to Disclose
 
Peush Sahni
No Relationships to Disclose
 
Sreenivas Vishnubhatla
No Relationships to Disclose
 
Sushma Bhatnagar
No Relationships to Disclose
 
Nihar Ranjan Dash
No Relationships to Disclose
 
Rakesh Kumar
No Relationships to Disclose
 
Vinod Raina
No Relationships to Disclose
 
Venkateswaran K Iyer
No Relationships to Disclose
 
Seema Mishra
No Relationships to Disclose